<?xml version="1.0" encoding="UTF-8"?>
<p>There may be ethnic variation in the motor complications of PD treatment. Dyskinesia and ‘wearing off’ have been extensively studied in PD patients from North America and Europe, but research on this topic is patchy in other regions of the world, especially in multi-ethnic cohorts. Asian patients appear most likely to experience dyskinesia and as a consequence lower doses of dopaminergic drugs are often recommended [
 <xref rid="ref035" ref-type="bibr">35, 69</xref>]. In an international survey Japanese physicians reported the lowest prevalence of dyskinesia in their patients. However, they were also the least likely to use levodopa monotherapy, preferring a combination of dopamine agonists and levodopa, which could be a contributing factor [
 <xref rid="ref070" ref-type="bibr">70</xref>].
</p>
